APO Research
Talk to an analyst

APO RESEARCH · REPORT

Point-of-Care Testing (POCT)

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Selected research

Market Outlook & Growth Opportunities

Global Point-of-Care Testing (POCT) Market Outlook and Growth Opportunities 2026

21 December 2025214 pages

Choose your research edition.

Industry ResearchPoint-of-Care Testing (POCT) Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Point-of-Care Testing (POCT) Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Point-of-Care Testing (POCT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Point-of-Care Testing (POCT) Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Point-of-Care Testing (POCT) Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.

This report provides an overview of the global Point-of-Care Testing (POCT) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Point-of-Care Testing (POCT) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Point-of-Care Testing (POCT) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Point-of-Care Testing (POCT) market size, projected growth trends, production technologies, key applications, and end-use industries.

Point-of-Care Testing (POCT) Segment by Company

Roche

Abbott

Johnson & Johnson

Siemens Healthcare

Danaher

Ascensia

Bio-Rad Laboratories

BioMerieux

ARKRAY

Nova Biomedical

Trividia Health

Quidel

Accriva

OraSure Technologies

Helena Laboratories

A. Menarini Diagnostics

Abaxis (Zoetis)

Ortho Clinical Diagnostics

Phamatech

Chembio Diagnostics

Trinity Biotech

ELITech Group

Response Biomedical

Princeton BioMeditech

Alfa Wassermann

Point-of-Care Testing (POCT) Segment by Type

Blood Glucose Testing

Infectious Diseases Testing

Cardiac Markers Testing

Coagulation Testing

Pregnancy and Fertility Testing

Blood Gas/Electrolytes Testing

Urinalysis Testing

Point-of-Care Testing (POCT) Segment by Application

Clinics

Hospitals

Laboratory

Others

Point-of-Care Testing (POCT) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Point-of-Care Testing (POCT) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Point-of-Care Testing (POCT) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Point-of-Care Testing (POCT) significant trends, drivers, influence factors in global and regions.

6. To analyze Point-of-Care Testing (POCT) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-Care Testing (POCT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Point-of-Care Testing (POCT) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-Care Testing (POCT).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Point-of-Care Testing (POCT) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Point-of-Care Testing (POCT) industry.

Chapter 3: Detailed analysis of Point-of-Care Testing (POCT) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Point-of-Care Testing (POCT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Point-of-Care Testing (POCT) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Point-of-Care Testing (POCT) Industry Trends Table 2. Point-of-Care Testing (POCT) Industry Drivers Table 3. Point-of-Care Testing (POCT) Industry Opportunities and Challenges Table 4. Point-of-Care Testing (POCT) Industry Restraints Table 5. Global Point-of-Care Testing (POCT) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Point-of-Care Testing (POCT) Revenue Share by Company (2021-2026) Table 7. Global Point-of-Care Testing (POCT) Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Point-of-Care Testing (POCT) Sales Volume Share by Company (2021-2026) Table 9. Global Point-of-Care Testing (POCT) Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Point-of-Care Testing (POCT) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Point-of-Care Testing (POCT) Key Company Manufacturing Base & Headquarters Table 12. Global Point-of-Care Testing (POCT) Company, Product Type & Application Table 13. Global Point-of-Care Testing (POCT) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Point-of-Care Testing (POCT) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Blood Glucose Testing Table 18. Significant Companies of Infectious Diseases Testing Table 19. Significant Companies of Cardiac Markers Testing Table 20. Significant Companies of Coagulation Testing Table 21. Significant Companies of Pregnancy and Fertility Testing Table 22. Significant Companies of Blood Gas/Electrolytes Testing Table 23. Significant Companies of Urinalysis Testing Table 24. Global Point-of-Care Testing (POCT) Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 25. Global Point-of-Care Testing (POCT) Sales Volume by Type (2021-2026) & (M Units) Table 26. Global Point-of-Care Testing (POCT) Sales Volume by Type (2027-2032) & (M Units) Table 27. Global Point-of-Care Testing (POCT) Sales Volume Share by Type (2021-2026) Table 28. Global Point-of-Care Testing (POCT) Sales Volume Share by Type (2027-2032) Table 29. Global Point-of-Care Testing (POCT) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Point-of-Care Testing (POCT) Sales Value by Type (2021-2026) & (US$ Million) Table 31. Global Point-of-Care Testing (POCT) Sales Value by Type (2027-2032) & (US$ Million) Table 32. Global Point-of-Care Testing (POCT) Sales Value Share by Type (2021-2026) Table 33. Global Point-of-Care Testing (POCT) Sales Value Share by Type (2027-2032) Table 34. Significant Companies of Clinics Table 35. Significant Companies of Hospitals Table 36. Significant Companies of Laboratory Table 37. Significant Companies of Others Table 38. Global Point-of-Care Testing (POCT) Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 39. Global Point-of-Care Testing (POCT) Sales Volume by Application (2021-2026) & (M Units) Table 40. Global Point-of-Care Testing (POCT) Sales Volume by Application (2027-2032) & (M Units) Table 41. Global Point-of-Care Testing (POCT) Sales Volume Share by Application (2021-2026) Table 42. Global Point-of-Care Testing (POCT) Sales Volume Share by Application (2027-2032) Table 43. Global Point-of-Care Testing (POCT) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Point-of-Care Testing (POCT) Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Point-of-Care Testing (POCT) Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Point-of-Care Testing (POCT) Sales Value Share by Application (2021-2026) Table 47. Global Point-of-Care Testing (POCT) Sales Value Share by Application (2027-2032) Table 48. Global Point-of-Care Testing (POCT) Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 49. Global Point-of-Care Testing (POCT) Sales by Region (2021-2026) & (M Units) Table 50. Global Point-of-Care Testing (POCT) Sales Market Share by Region (2021-2026) Table 51. Global Point-of-Care Testing (POCT) Sales by Region (2027-2032) & (M Units) Table 52. Global Point-of-Care Testing (POCT) Sales Market Share by Region (2027-2032) Table 53. Global Point-of-Care Testing (POCT) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Point-of-Care Testing (POCT) Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Point-of-Care Testing (POCT) Sales Value Share by Region (2021-2026) Table 56. Global Point-of-Care Testing (POCT) Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Point-of-Care Testing (POCT) Sales Value Share by Region (2027-2032) Table 58. Global Point-of-Care Testing (POCT) Market Average Price (USD/Unit) by Region (2021-2026) Table 59. Global Point-of-Care Testing (POCT) Market Average Price (USD/Unit) by Region (2027-2032) Table 60. Global Point-of-Care Testing (POCT) Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 61. Global Point-of-Care Testing (POCT) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 63. Global Point-of-Care Testing (POCT) Sales Market Share by Country (2021-2026) Table 64. Global Point-of-Care Testing (POCT) Sales by Country (2027-2032) & (M Units) Table 65. Global Point-of-Care Testing (POCT) Sales Market Share by Country (2027-2032) Table 66. Global Point-of-Care Testing (POCT) Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Point-of-Care Testing (POCT) Sales Value Market Share by Country (2021-2026) Table 68. Global Point-of-Care Testing (POCT) Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Point-of-Care Testing (POCT) Sales Value Market Share by Country (2027-2032) Table 70. Roche Company Information Table 71. Roche Business Overview Table 72. Roche Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 73. Roche Point-of-Care Testing (POCT) Product Portfolio Table 74. Roche Recent Development Table 75. Abbott Company Information Table 76. Abbott Business Overview Table 77. Abbott Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 78. Abbott Point-of-Care Testing (POCT) Product Portfolio Table 79. Abbott Recent Development Table 80. Johnson & Johnson Company Information Table 81. Johnson & Johnson Business Overview Table 82. Johnson & Johnson Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 83. Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio Table 84. Johnson & Johnson Recent Development Table 85. Siemens Healthcare Company Information Table 86. Siemens Healthcare Business Overview Table 87. Siemens Healthcare Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio Table 89. Siemens Healthcare Recent Development Table 90. Danaher Company Information Table 91. Danaher Business Overview Table 92. Danaher Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Danaher Point-of-Care Testing (POCT) Product Portfolio Table 94. Danaher Recent Development Table 95. Ascensia Company Information Table 96. Ascensia Business Overview Table 97. Ascensia Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Ascensia Point-of-Care Testing (POCT) Product Portfolio Table 99. Ascensia Recent Development Table 100. Bio-Rad Laboratories Company Information Table 101. Bio-Rad Laboratories Business Overview Table 102. Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio Table 104. Bio-Rad Laboratories Recent Development Table 105. BioMerieux Company Information Table 106. BioMerieux Business Overview Table 107. BioMerieux Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. BioMerieux Point-of-Care Testing (POCT) Product Portfolio Table 109. BioMerieux Recent Development Table 110. ARKRAY Company Information Table 111. ARKRAY Business Overview Table 112. ARKRAY Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. ARKRAY Point-of-Care Testing (POCT) Product Portfolio Table 114. ARKRAY Recent Development Table 115. Nova Biomedical Company Information Table 116. Nova Biomedical Business Overview Table 117. Nova Biomedical Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio Table 119. Nova Biomedical Recent Development Table 120. Trividia Health Company Information Table 121. Trividia Health Business Overview Table 122. Trividia Health Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. Trividia Health Point-of-Care Testing (POCT) Product Portfolio Table 124. Trividia Health Recent Development Table 125. Quidel Company Information Table 126. Quidel Business Overview Table 127. Quidel Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. Quidel Point-of-Care Testing (POCT) Product Portfolio Table 129. Quidel Recent Development Table 130. Accriva Company Information Table 131. Accriva Business Overview Table 132. Accriva Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 133. Accriva Point-of-Care Testing (POCT) Product Portfolio Table 134. Accriva Recent Development Table 135. OraSure Technologies Company Information Table 136. OraSure Technologies Business Overview Table 137. OraSure Technologies Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 138. OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio Table 139. OraSure Technologies Recent Development Table 140. Helena Laboratories Company Information Table 141. Helena Laboratories Business Overview Table 142. Helena Laboratories Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 143. Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio Table 144. Helena Laboratories Recent Development Table 145. A. Menarini Diagnostics Company Information Table 146. A. Menarini Diagnostics Business Overview Table 147. A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 148. A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio Table 149. A. Menarini Diagnostics Recent Development Table 150. Abaxis (Zoetis) Company Information Table 151. Abaxis (Zoetis) Business Overview Table 152. Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 153. Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio Table 154. Abaxis (Zoetis) Recent Development Table 155. Ortho Clinical Diagnostics Company Information Table 156. Ortho Clinical Diagnostics Business Overview Table 157. Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 158. Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio Table 159. Ortho Clinical Diagnostics Recent Development Table 160. Phamatech Company Information Table 161. Phamatech Business Overview Table 162. Phamatech Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 163. Phamatech Point-of-Care Testing (POCT) Product Portfolio Table 164. Phamatech Recent Development Table 165. Chembio Diagnostics Company Information Table 166. Chembio Diagnostics Business Overview Table 167. Chembio Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 168. Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio Table 169. Chembio Diagnostics Recent Development Table 170. Trinity Biotech Company Information Table 171. Trinity Biotech Business Overview Table 172. Trinity Biotech Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 173. Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio Table 174. Trinity Biotech Recent Development Table 175. ELITech Group Company Information Table 176. ELITech Group Business Overview Table 177. ELITech Group Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 178. ELITech Group Point-of-Care Testing (POCT) Product Portfolio Table 179. ELITech Group Recent Development Table 180. Response Biomedical Company Information Table 181. Response Biomedical Business Overview Table 182. Response Biomedical Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 183. Response Biomedical Point-of-Care Testing (POCT) Product Portfolio Table 184. Response Biomedical Recent Development Table 185. Princeton BioMeditech Company Information Table 186. Princeton BioMeditech Business Overview Table 187. Princeton BioMeditech Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 188. Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio Table 189. Princeton BioMeditech Recent Development Table 190. Alfa Wassermann Company Information Table 191. Alfa Wassermann Business Overview Table 192. Alfa Wassermann Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 193. Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio Table 194. Alfa Wassermann Recent Development Table 195. Key Raw Materials Table 196. Raw Materials Key Suppliers Table 197. Point-of-Care Testing (POCT) Distributors List Table 198. Point-of-Care Testing (POCT) Customers List Table 199. Research Programs/Design for This Report Table 200. Authors List of This Report Table 201. Secondary Sources Table 202. Primary Sources List of Figures Figure 1. Point-of-Care Testing (POCT) Product Image Figure 2. Global Point-of-Care Testing (POCT) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Point-of-Care Testing (POCT) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Point-of-Care Testing (POCT) Sales (2021-2032) & (M Units) Figure 5. Global Point-of-Care Testing (POCT) Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Point-of-Care Testing (POCT) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Blood Glucose Testing Image Figure 10. Infectious Diseases Testing Image Figure 11. Cardiac Markers Testing Image Figure 12. Coagulation Testing Image Figure 13. Pregnancy and Fertility Testing Image Figure 14. Blood Gas/Electrolytes Testing Image Figure 15. Urinalysis Testing Image Figure 16. Global Point-of-Care Testing (POCT) Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 17. Global Point-of-Care Testing (POCT) Sales Volume Share 2021 VS 2025 VS 2032 Figure 18. Global Point-of-Care Testing (POCT) Sales Volume Share by Type (2021-2032) Figure 19. Global Point-of-Care Testing (POCT) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Point-of-Care Testing (POCT) Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Point-of-Care Testing (POCT) Sales Value Share by Type (2021-2032) Figure 22. Clinics Image Figure 23. Hospitals Image Figure 24. Laboratory Image Figure 25. Others Image Figure 26. Global Point-of-Care Testing (POCT) Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 27. Global Point-of-Care Testing (POCT) Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Point-of-Care Testing (POCT) Sales Volume Share by Application (2021-2032) Figure 29. Global Point-of-Care Testing (POCT) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Point-of-Care Testing (POCT) Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Point-of-Care Testing (POCT) Sales Value Share by Application (2021-2032) Figure 32. Global Point-of-Care Testing (POCT) Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 33. Global Point-of-Care Testing (POCT) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Point-of-Care Testing (POCT) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Point-of-Care Testing (POCT) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Point-of-Care Testing (POCT) Sales Value (2021-2032) & (US$ Million) Figure 37. North America Point-of-Care Testing (POCT) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Point-of-Care Testing (POCT) Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Point-of-Care Testing (POCT) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Point-of-Care Testing (POCT) Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Point-of-Care Testing (POCT) Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Point-of-Care Testing (POCT) Sales Value (2021-2032) & (US$ Million) Figure 43. South America Point-of-Care Testing (POCT) Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Point-of-Care Testing (POCT) Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Point-of-Care Testing (POCT) Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Point-of-Care Testing (POCT) Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Point-of-Care Testing (POCT) Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Glucose Testing
  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Pregnancy and Fertility Testing
  • Blood Gas/Electrolytes Testing
  • Urinalysis Testing
Applications
  • Clinics
  • Hospitals
  • Laboratory
  • Others
Companies covered
  • Roche
  • Abbott
  • Johnson & Johnson
  • Siemens Healthcare
  • Danaher
  • Ascensia
  • Bio-Rad Laboratories
  • BioMerieux
  • ARKRAY
  • Nova Biomedical
  • Trividia Health
  • Quidel
  • Accriva
  • OraSure Technologies
  • Helena Laboratories
  • A. Menarini Diagnostics
  • Abaxis (Zoetis)
  • Ortho Clinical Diagnostics
  • Phamatech
  • Chembio Diagnostics
  • Trinity Biotech
  • ELITech Group
  • Response Biomedical
  • Princeton BioMeditech
  • Alfa Wassermann

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Point-of-Care Testing (POCT) Sales Value (2021-2032)
  4. 1.2.2 Global Point-of-Care Testing (POCT) Sales Volume (2021-2032)
  5. 1.2.3 Global Point-of-Care Testing (POCT) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Point-of-Care Testing (POCT) Market Dynamics
  1. 2.1 Point-of-Care Testing (POCT) Industry Trends
  2. 2.2 Point-of-Care Testing (POCT) Industry Drivers
  3. 2.3 Point-of-Care Testing (POCT) Industry Opportunities and Challenges
  4. 2.4 Point-of-Care Testing (POCT) Industry Restraints
3 Point-of-Care Testing (POCT) Market by Company
  1. 3.1 Global Point-of-Care Testing (POCT) Company Revenue Ranking in 2025
  2. 3.2 Global Point-of-Care Testing (POCT) Revenue by Company (2021-2026)
  3. 3.3 Global Point-of-Care Testing (POCT) Sales Volume by Company (2021-2026)
  4. 3.4 Global Point-of-Care Testing (POCT) Average Price by Company (2021-2026)
  5. 3.5 Global Point-of-Care Testing (POCT) Company Ranking (2024-2026)
  6. 3.6 Global Point-of-Care Testing (POCT) Company Manufacturing Base and Headquarters
  7. 3.7 Global Point-of-Care Testing (POCT) Company Product Type and Application
  8. 3.8 Global Point-of-Care Testing (POCT) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Point-of-Care Testing (POCT) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Point-of-Care Testing (POCT) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Point-of-Care Testing (POCT) Market by Type
  1. 4.1 Point-of-Care Testing (POCT) Type Introduction
  2. 4.1.1 Blood Glucose Testing
  3. 4.1.2 Infectious Diseases Testing
  4. 4.1.3 Cardiac Markers Testing
  5. 4.1.4 Coagulation Testing
  6. 4.1.5 Pregnancy and Fertility Testing
  7. 4.1.6 Blood Gas/Electrolytes Testing
  8. 4.1.7 Urinalysis Testing
  9. 4.2 Global Point-of-Care Testing (POCT) Sales Volume by Type
  10. 4.2.1 Global Point-of-Care Testing (POCT) Sales Volume by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Point-of-Care Testing (POCT) Sales Volume by Type (2021-2032)
  12. 4.2.3 Global Point-of-Care Testing (POCT) Sales Volume Share by Type (2021-2032)
  13. 4.3 Global Point-of-Care Testing (POCT) Sales Value by Type
  14. 4.3.1 Global Point-of-Care Testing (POCT) Sales Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Point-of-Care Testing (POCT) Sales Value by Type (2021-2032)
  16. 4.3.3 Global Point-of-Care Testing (POCT) Sales Value Share by Type (2021-2032)
5 Point-of-Care Testing (POCT) Market by Application
  1. 5.1 Point-of-Care Testing (POCT) Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Laboratory
  5. 5.1.4 Others
  6. 5.2 Global Point-of-Care Testing (POCT) Sales Volume by Application
  7. 5.2.1 Global Point-of-Care Testing (POCT) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Point-of-Care Testing (POCT) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Point-of-Care Testing (POCT) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Point-of-Care Testing (POCT) Sales Value by Application
  11. 5.3.1 Global Point-of-Care Testing (POCT) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Point-of-Care Testing (POCT) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application (2021-2032)
6 Point-of-Care Testing (POCT) Regional Sales and Value Analysis
  1. 6.1 Global Point-of-Care Testing (POCT) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Point-of-Care Testing (POCT) Sales by Region (2021-2032)
  3. 6.2.1 Global Point-of-Care Testing (POCT) Sales by Region: 2021-2026
  4. 6.2.2 Global Point-of-Care Testing (POCT) Sales by Region (2027-2032)
  5. 6.3 Global Point-of-Care Testing (POCT) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Point-of-Care Testing (POCT) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Point-of-Care Testing (POCT) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Point-of-Care Testing (POCT) Sales Value by Region (2027-2032)
  9. 6.5 Global Point-of-Care Testing (POCT) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Point-of-Care Testing (POCT) Sales Value (2021-2032)
  12. 6.6.2 North America Point-of-Care Testing (POCT) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Point-of-Care Testing (POCT) Sales Value (2021-2032)
  15. 6.7.2 Europe Point-of-Care Testing (POCT) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Point-of-Care Testing (POCT) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Point-of-Care Testing (POCT) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Point-of-Care Testing (POCT) Sales Value (2021-2032)
  21. 6.9.2 South America Point-of-Care Testing (POCT) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Point-of-Care Testing (POCT) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Point-of-Care Testing (POCT) Sales Value Share by Country, 2025 VS 2032
7 Point-of-Care Testing (POCT) Country-level Sales and Value Analysis
  1. 7.1 Global Point-of-Care Testing (POCT) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Point-of-Care Testing (POCT) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Point-of-Care Testing (POCT) Sales by Country (2021-2032)
  4. 7.3.1 Global Point-of-Care Testing (POCT) Sales by Country (2021-2026)
  5. 7.3.2 Global Point-of-Care Testing (POCT) Sales by Country (2027-2032)
  6. 7.4 Global Point-of-Care Testing (POCT) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Point-of-Care Testing (POCT) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Point-of-Care Testing (POCT) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Point-of-Care Testing (POCT) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Point-of-Care Testing (POCT) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Point-of-Care Testing (POCT) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Roche Point-of-Care Testing (POCT) Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Abbott
  8. 8.2.1 Abbott Company Information
  9. 8.2.2 Abbott Business Overview
  10. 8.2.3 Abbott Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Abbott Point-of-Care Testing (POCT) Product Portfolio
  12. 8.2.5 Abbott Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Siemens Healthcare
  20. 8.4.1 Siemens Healthcare Company Information
  21. 8.4.2 Siemens Healthcare Business Overview
  22. 8.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio
  24. 8.4.5 Siemens Healthcare Recent Developments
  25. 8.5 Danaher
  26. 8.5.1 Danaher Company Information
  27. 8.5.2 Danaher Business Overview
  28. 8.5.3 Danaher Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Danaher Point-of-Care Testing (POCT) Product Portfolio
  30. 8.5.5 Danaher Recent Developments
  31. 8.6 Ascensia
  32. 8.6.1 Ascensia Company Information
  33. 8.6.2 Ascensia Business Overview
  34. 8.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio
  36. 8.6.5 Ascensia Recent Developments
  37. 8.7 Bio-Rad Laboratories
  38. 8.7.1 Bio-Rad Laboratories Company Information
  39. 8.7.2 Bio-Rad Laboratories Business Overview
  40. 8.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio
  42. 8.7.5 Bio-Rad Laboratories Recent Developments
  43. 8.8 BioMerieux
  44. 8.8.1 BioMerieux Company Information
  45. 8.8.2 BioMerieux Business Overview
  46. 8.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio
  48. 8.8.5 BioMerieux Recent Developments
  49. 8.9 ARKRAY
  50. 8.9.1 ARKRAY Company Information
  51. 8.9.2 ARKRAY Business Overview
  52. 8.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio
  54. 8.9.5 ARKRAY Recent Developments
  55. 8.10 Nova Biomedical
  56. 8.10.1 Nova Biomedical Company Information
  57. 8.10.2 Nova Biomedical Business Overview
  58. 8.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio
  60. 8.10.5 Nova Biomedical Recent Developments
  61. 8.11 Trividia Health
  62. 8.11.1 Trividia Health Company Information
  63. 8.11.2 Trividia Health Business Overview
  64. 8.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio
  66. 8.11.5 Trividia Health Recent Developments
  67. 8.12 Quidel
  68. 8.12.1 Quidel Company Information
  69. 8.12.2 Quidel Business Overview
  70. 8.12.3 Quidel Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Quidel Point-of-Care Testing (POCT) Product Portfolio
  72. 8.12.5 Quidel Recent Developments
  73. 8.13 Accriva
  74. 8.13.1 Accriva Company Information
  75. 8.13.2 Accriva Business Overview
  76. 8.13.3 Accriva Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Accriva Point-of-Care Testing (POCT) Product Portfolio
  78. 8.13.5 Accriva Recent Developments
  79. 8.14 OraSure Technologies
  80. 8.14.1 OraSure Technologies Company Information
  81. 8.14.2 OraSure Technologies Business Overview
  82. 8.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio
  84. 8.14.5 OraSure Technologies Recent Developments
  85. 8.15 Helena Laboratories
  86. 8.15.1 Helena Laboratories Company Information
  87. 8.15.2 Helena Laboratories Business Overview
  88. 8.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio
  90. 8.15.5 Helena Laboratories Recent Developments
  91. 8.16 A. Menarini Diagnostics
  92. 8.16.1 A. Menarini Diagnostics Company Information
  93. 8.16.2 A. Menarini Diagnostics Business Overview
  94. 8.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio
  96. 8.16.5 A. Menarini Diagnostics Recent Developments
  97. 8.17 Abaxis (Zoetis)
  98. 8.17.1 Abaxis (Zoetis) Company Information
  99. 8.17.2 Abaxis (Zoetis) Business Overview
  100. 8.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio
  102. 8.17.5 Abaxis (Zoetis) Recent Developments
  103. 8.18 Ortho Clinical Diagnostics
  104. 8.18.1 Ortho Clinical Diagnostics Company Information
  105. 8.18.2 Ortho Clinical Diagnostics Business Overview
  106. 8.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio
  108. 8.18.5 Ortho Clinical Diagnostics Recent Developments
  109. 8.19 Phamatech
  110. 8.19.1 Phamatech Company Information
  111. 8.19.2 Phamatech Business Overview
  112. 8.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio
  114. 8.19.5 Phamatech Recent Developments
  115. 8.20 Chembio Diagnostics
  116. 8.20.1 Chembio Diagnostics Company Information
  117. 8.20.2 Chembio Diagnostics Business Overview
  118. 8.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio
  120. 8.20.5 Chembio Diagnostics Recent Developments
  121. 8.21 Trinity Biotech
  122. 8.21.1 Trinity Biotech Company Information
  123. 8.21.2 Trinity Biotech Business Overview
  124. 8.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio
  126. 8.21.5 Trinity Biotech Recent Developments
  127. 8.22 ELITech Group
  128. 8.22.1 ELITech Group Company Information
  129. 8.22.2 ELITech Group Business Overview
  130. 8.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio
  132. 8.22.5 ELITech Group Recent Developments
  133. 8.23 Response Biomedical
  134. 8.23.1 Response Biomedical Company Information
  135. 8.23.2 Response Biomedical Business Overview
  136. 8.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio
  138. 8.23.5 Response Biomedical Recent Developments
  139. 8.24 Princeton BioMeditech
  140. 8.24.1 Princeton BioMeditech Company Information
  141. 8.24.2 Princeton BioMeditech Business Overview
  142. 8.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio
  144. 8.24.5 Princeton BioMeditech Recent Developments
  145. 8.25 Alfa Wassermann
  146. 8.25.1 Alfa Wassermann Company Information
  147. 8.25.2 Alfa Wassermann Business Overview
  148. 8.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio
  150. 8.25.5 Alfa Wassermann Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Point-of-Care Testing (POCT) Value Chain Analysis
  2. 9.1.1 Point-of-Care Testing (POCT) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Point-of-Care Testing (POCT) Sales Mode & Process
  6. 9.2 Point-of-Care Testing (POCT) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Point-of-Care Testing (POCT) Distributors
  9. 9.2.3 Point-of-Care Testing (POCT) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst